doi:10.1155/2017/4650182
Federal Food, Drug, and Cosmetic Act
Peptides expected to return to legal compounding status include: BPC-157 - studied for tissue repair, gut healing, and inflammation reduction Thymosin Alpha-1 - an immune-modulating peptide used in infectious disease and oncology support TB-500 (Thymosin Beta-4) - studied for muscle repair, flexibility, and recovery CJC-1295 and Ipamorelin - growth hormone-releasing peptides supporting sleep, metabolism, and lean muscle AOD-9604 - a peptide fragment studied for fat metabolism Selank and Semax - neuropeptides studied for cognitive function and anxiety GHK-Cu - a copper peptide studied for wound healing and regeneration MOTS-C - a mitochondrial peptide studied for metabolic regulation Important: Category 1 reclassification is not the same as FDA approval
Whether youre recovering from a sports-related injury or seeking relief from inflammatory bowel disease, BPC 157 Peptides offer a promising solution to support your bodys natural healing mechanisms
It also offers anti-inflammatory, gut, and organ support
Knowing when shots are needed helps doctors give better care and improve health outcomes
